News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
47,876 Results
Type
Article (1661)
Company Profile (19)
Press Release (46196)
Multimedia
Podcasts (4)
Webinars (1)
Section
Business (15999)
Career Advice (45)
Deals (2632)
Drug Delivery (22)
Drug Development (4541)
Employer Resources (16)
FDA (753)
Job Trends (1090)
News (23381)
Policy (1818)
Tag
Academia (138)
Accelerated approval (1)
Allergies (6)
Alliances (1784)
ALS (6)
Alzheimer's disease (150)
Antibody-drug conjugate (ADC) (24)
Approvals (786)
Artificial intelligence (60)
Autoimmune disease (8)
Bankruptcy (11)
Best Places to Work (1077)
BIOSECURE Act (11)
Biosimilars (21)
Biotechnology (20)
Bladder cancer (5)
Brain cancer (7)
Breast cancer (61)
Cancer (410)
Cardiovascular disease (47)
Career advice (38)
Career pathing (4)
CAR-T (21)
CDC (3)
Cell therapy (69)
Cervical cancer (6)
Clinical research (4251)
Collaboration (129)
Compensation (30)
Complete response letters (1)
COVID-19 (49)
CRISPR (3)
C-suite (28)
Cystic fibrosis (5)
Data (450)
Depression (12)
Diabetes (42)
Diagnostics (509)
Digital health (6)
Diversity, equity & inclusion (2)
Drug discovery (42)
Drug pricing (20)
Drug shortages (4)
Duchenne muscular dystrophy (8)
Earnings (13323)
Editorial (8)
Employer branding (6)
Employer resources (13)
Events (5058)
Executive appointments (30)
FDA (1111)
Frontotemporal dementia (1)
Funding (106)
Gene editing (15)
Generative AI (9)
Gene therapy (46)
GLP-1 (129)
Government (283)
Grass and pollen (1)
Guidances (154)
Healthcare (1336)
HIV (12)
Huntington's disease (1)
IgA nephropathy (7)
Immunology and inflammation (44)
Immuno-oncology (7)
Indications (10)
Infectious disease (78)
Inflammatory bowel disease (16)
Influenza (4)
Intellectual property (55)
Interviews (12)
IPO (1874)
IRA (5)
Job creations (67)
Job search strategy (21)
JPM (13)
Labor market (8)
Layoffs (29)
Legal (278)
Liver cancer (11)
Lung cancer (43)
Lymphoma (45)
Machine learning (3)
Management (4)
Manufacturing (101)
MASH (46)
Medical device (972)
Medtech (977)
Mergers & acquisitions (855)
Metabolic disorders (193)
Multiple sclerosis (13)
NASH (2)
Neurodegenerative disease (26)
Neuropsychiatric disorders (14)
Neuroscience (268)
Neurotech (1)
NextGen: Class of 2026 (473)
Non-profit (253)
Now hiring (4)
Obesity (96)
Opinion (17)
Ovarian cancer (16)
Pain (25)
Pancreatic cancer (20)
Parkinson's disease (37)
Partnered (2)
Patents (107)
Patient recruitment (28)
Peanut (1)
People (1760)
Pharmaceutical (8)
Pharmacy benefit managers (3)
Phase 1 (1029)
Phase 2 (1962)
Phase 3 (1585)
Pipeline (735)
Policy (26)
Postmarket research (113)
Preclinical (344)
Press Release (1)
Prostate cancer (14)
Psychedelics (4)
Radiopharmaceuticals (30)
Rare diseases (61)
Real estate (150)
Recruiting (8)
Regulatory (1563)
Reports (21)
Research institute (143)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (1)
RSV (13)
Schizophrenia (24)
Series A (13)
Series B (6)
Sickle cell disease (9)
Special edition (8)
Spinal muscular atrophy (3)
Startups (117)
Stomach cancer (1)
Supply chain (8)
Tariffs (7)
The Weekly (4)
Vaccines (52)
Venture capital (9)
Weight loss (72)
Women's health (9)
Date
Today (17)
Last 7 days (59)
Last 30 days (190)
Last 365 days (3308)
2026 (242)
2025 (3537)
2024 (3801)
2023 (3648)
2022 (7781)
2021 (4929)
2020 (3574)
2019 (6477)
2018 (2103)
2017 (1490)
2016 (1188)
2015 (1632)
2014 (1054)
2013 (672)
2012 (587)
2011 (606)
2010 (569)
Location
Africa (27)
Alabama (4)
Arizona (22)
Asia (2767)
Australia (372)
California (908)
Canada (294)
China (93)
Colorado (31)
Connecticut (119)
Delaware (28)
Europe (7391)
Florida (189)
Georgia (35)
Idaho (5)
Illinois (54)
India (11)
Indiana (43)
Japan (87)
Kansas (1)
Kentucky (1)
Louisiana (6)
Maine (3)
Maryland (165)
Massachusetts (511)
Michigan (15)
Minnesota (62)
Mississippi (1)
Missouri (3)
Nebraska (2)
Nevada (7)
New Hampshire (12)
New Jersey (317)
New York (253)
North Carolina (142)
Northern California (432)
Ohio (19)
Oregon (7)
Pennsylvania (159)
Puerto Rico (2)
Rhode Island (1)
South America (43)
South Carolina (1)
Southern California (366)
Tennessee (4)
Texas (91)
United States (3249)
Utah (24)
Virginia (14)
Washington D.C. (11)
Washington State (75)
Wisconsin (6)
47,876 Results for "203".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma
February 10, 2026
·
6 min read
Press Releases
Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds
November 24, 2025
·
9 min read
Press Releases
Scilex Holding Company Announces Closing of Exercise of Warrants for $20.3 Million Gross Proceeds
November 26, 2025
·
8 min read
Press Releases
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease
December 23, 2025
·
3 min read
Press Releases
Verastem Oncology Provides Update on RAMP 203 Phase 1/2 Clinical Trial for Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
December 30, 2025
·
10 min read
Press Releases
YolTech Therapeutics Receives FDA IND Clearance to Initiate Global Pivotal Trial of In Vivo Gene-Editing Therapy YOLT-203 for Primary Hyperoxaluria Type 1 (PH1)
November 19, 2025
·
1 min read
Press Releases
Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress
December 11, 2025
·
10 min read
Press Releases
ProteinQure Announces First Patient Dosed in Phase I Clinical Trial of PQ203 in Advanced Metastatic Cancer
September 18, 2025
·
2 min read
Press Releases
Biotle Announces Preclinical PK/PD Results for BTL-203, a Next-Generation FcRn Inhibitor BTL-203 showed deep, sustained IgG reduction in Cynomolgus monkeys; translational modeling projects once-every-four-weeks subcutaneous dosing in humans
September 8, 2025
·
1 min read
Press Releases
AvenCell Therapeutics Announces IND Clearance and EMA Approval of Clinical Trial Application (CTA) for the QUADvance Study, a Phase I/II trial evaluating AVC-203, a Novel Allogeneic CD19/CD20 CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory B-cell malignancies
December 4, 2025
·
5 min read
1 of 4,788
Next
